Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Sci Stent Development Proceeding In-House; J&J Velocity Moves Fast

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific is pursuing the development of its next-generation coronary stent platform internally as well as with partner Medinol as a contingency to the ongoing uncertainties with the Israeli firm.
Advertisement

Related Content

LifeScan Defective SureStep Glucose Meter Civil Trial Slated For September
LifeScan Defective SureStep Glucose Meter Civil Trial Slated For September
Novoste Meeting With FDA On Beta-Cath Labeling Issues Week Of Oct. 23
NIR paclitaxel stent study
Johnson & Johnson/Cordis
Johnson & Johnson/Cordis
Advertisement
UsernamePublicRestriction

Register

MT014004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel